Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 31, 2001 - Issue 3
90
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Human adult and foetal liver sulphotransferases: inhibition by mefenamic acid and salicylic acid

, , , &
Pages 153-161 | Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Katsuhisa Kurogi, Mohammed I. Rasool, Fatemah A. Alherz, Amal A. El Daibani, Ahsan F. Bairam, Maryam S. Abunnaja, Shin Yasuda, Lauren J. Wilson, Ying Hui & Ming-Cheh Liu. (2021) SULT genetic polymorphisms: physiological, pharmacological and clinical implications. Expert Opinion on Drug Metabolism & Toxicology 17:7, pages 767-784.
Read now
Margaret O. James & Sriram Ambadapadi. (2013) Interactions of cytosolic sulfotransferases with xenobiotics. Drug Metabolism Reviews 45:4, pages 401-414.
Read now
M Strolin Benedetti, R Whomsley & E L Baltes. (2005) Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations. Expert Opinion on Drug Metabolism & Toxicology 1:3, pages 447-471.
Read now
C. De Santi, A. Pietrabissa, F. Mosca, A. Rane & G. M. Pacifici. (2002) Inhibition of phenol sulfotransferase (SULT1A1) by quercetin in human adult and foetal livers. Xenobiotica 32:5, pages 363-368.
Read now

Articles from other publishers (17)

Ruoyue Huang, Chunyan Wang, Zhanxuan E. Wu, Qi Zhao, Jingyi Duan, Wen Huang, Yan Cheng, Beiwei Zhu & Fei Li. (2023) Metabolomics reveals that sulfotransferase 1 may regulate colchicine-induced liver injury. Chemico-Biological Interactions 386, pages 110776.
Crossref
Michael W. Duffel. 2023. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Yan Rong & Tony K.L. Kiang. (2021) Characterization of human sulfotransferases catalyzing the formation of p-cresol sulfate and identification of mefenamic acid as a potent metabolism inhibitor and potential therapeutic agent for detoxification. Toxicology and Applied Pharmacology 425, pages 115553.
Crossref
Emanuela Testai, Camille Bechaux, Franca M. Buratti, Keyvin Darney, Emma Di Consiglio, Emma E.J. Kasteel, Nynke I. Kramer, Leonie S. Lautz, Nicoletta Santori, Zoi‐Vasiliki Skaperda, Dimitrios Kouretas, Laura Turco & Susanna Vichi. (2021) Modelling human variability in toxicokinetic and toxicodynamic processes using Bayesian meta‐analysis, physiologically‐based modelling and in vitro systems. EFSA Supporting Publications 18:4.
Crossref
Paola Mian, Karel Allegaert, Sigrid Conings, Pieter Annaert, Dick Tibboel, Marc Pfister, Kristel van Calsteren, John N. van den Anker & André Dallmann. (2020) Integration of Placental Transfer in a Fetal–Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus. Clinical Pharmacokinetics 59:7, pages 911-925.
Crossref
Mohammed I. Rasool, Ahsan F. Bairam, Saud A. Gohal, Amal A. El Daibani, Fatemah A. Alherz, Maryam S. Abunnaja, Eid S. Alatwi, Katsuhisa Kurogi & Ming-Cheh Liu. (2019) Effects of the human SULT1A1 polymorphisms on the sulfation of acetaminophen,O-desmethylnaproxen, and tapentadol. Pharmacological Reports 71:2, pages 257-265.
Crossref
M.W. Duffel. 2018. Comprehensive Toxicology. Comprehensive Toxicology 407 428 .
Ahsan F. Bairam, Mohammed I. Rasool, Katsuhisa Kurogi & Ming-Cheh Liu. (2017) On the Molecular Basis Underlying the Metabolism of Tapentadol Through Sulfation. European Journal of Drug Metabolism and Pharmacokinetics 42:5, pages 793-800.
Crossref
Alexander V. LyubimovSouzan Yanni & Karel Allegaert. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions 1 44 .
Y J Blumenfeld, M F Reynolds-May, R B Altman & Y Y El-Sayed. (2009) Maternal–fetal and neonatal pharmacogenomics: a review of current literature. Journal of Perinatology 30:9, pages 571-579.
Crossref
Takashi Mizuma. (2008) Assessment of Presystemic and Systemic Intestinal Availability of Orally Administered Drugs Using In Vitro and In Vivo Data in Humans: Intestinal Sulfation Metabolism Impacts Presystemic Availability Much More Than Systemic Availability of Salbutamol, SULT1A3 Substrate. Journal of Pharmaceutical Sciences 97:12, pages 5471-5476.
Crossref
Araba A. Adjei, Andrea Gaedigk, Stephen D. Simon, Richard M. Weinshilboum & J. Steven Leeder. (2008) Interindividual variability in acetaminophen sulfation by human fetal liver: Implications for pharmacogenetic investigations of drug‐induced birth defects. Birth Defects Research Part A: Clinical and Molecular Teratology 82:3, pages 155-165.
Crossref
Paraskevi Gaganis, John O. Miners & Kathleen M. Knights. (2007) Glucuronidation of fenamates: Kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7. Biochemical Pharmacology 73:10, pages 1683-1691.
Crossref
Zhengbo Duanmu, Amy Weckle, Sevasti B. Koukouritaki, Ronald N. Hines, Josie L. Falany, Charles N. Falany, Thomas A. Kocarek & Melissa Runge-Morris. (2006) Developmental Expression of Aryl, Estrogen, and Hydroxysteroid Sulfotransferases in Pre- and Postnatal Human Liver. Journal of Pharmacology and Experimental Therapeutics 316:3, pages 1310-1317.
Crossref
Gian Maria Pacifici. (2005) Sulfation of drugs and hormones in mid-gestation human fetus. Early Human Development 81:7, pages 573-581.
Crossref
Gian Maria Pacifici. 2005. Human Cytosolic Sulfotransferases. Human Cytosolic Sulfotransferases 157 177 .
M. Strolin Benedetti & E.L. Baltes. (2003) Drug metabolism and disposition in children. Fundamental & Clinical Pharmacology 17:3, pages 281-299.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.